Okay, let's tackle this question step by step. The patient is a diabetic with hypertension. His blood pressure is 164/102, which is stage 2 hypertension. The question is about the most suitable drug for him.

First, I need to recall the guidelines for managing hypertension in diabetics. The American Diabetes Association (ADA) recommends ACE inhibitors or ARBs as first-line agents because they provide renal protection. Diabetic patients are at higher risk for kidney damage, so protecting the kidneys is crucial.

Looking at the options provided, even though they aren't listed here, the correct answer would be either an ACE inhibitor or an ARB. Let's assume the options include these classes. For example, if option C is an ACE inhibitor like lisinopril, that would be correct.

Why not other classes? Beta-blockers or thiazide diuretics might be used in the general population, but in diabetics, they aren't first-line. Calcium channel blockers are an alternative but not the first choice. So, the wrong options would be those not in the ACE/ARB category.

The clinical pearl here is that for diabetics with hypertension, ACE inhibitors or ARBs are preferred due to their renal protective effects. This is a high-yield fact for exams like NEET PG or USMLE. The answer should reflect that understanding.

**Core Concept**
Hypertension management in diabetic patients prioritizes renal protection. **ACE inhibitors** or **angiotensin receptor blockers (ARBs)** are first-line due to their ability to reduce proteinuria and slow diabetic nephropathy progression.

**Why the Correct Answer is Right**
ACE inhibitors (e.g., lisinopril) and ARBs (e.g., losartan) inhibit the renin-angiotensin-aldosterone system (RAAS), lowering systemic vascular resistance and blood pressure. They also decrease glomerular hyperfiltration and oxidative stress in diabetic kidneys, delaying end-stage renal disease. These agents are specifically recommended by guidelines (e.g., ADA, NICE) for diabetics with hypertension.

**Why Each Wrong Option is Incorrect**
**Option A:** Beta-blockers (e.g., metoprolol) are less preferred in diabetics due to masking hypoglycemia symptoms and potential adverse metabolic effects.
**Option B:** Thiazide diuretics (e.g., hydrochlorothiazide) may worsen glucose control and are not first-line in diabetes.
**Option D:** Calcium channel blockers (e.g., amlodipine) are second-line in diabetics unless RAAS inhibition is contraindicated.

**Clinical Pearl / High-Yield Fact**
Never forget: **ACE inhibitors/ARBs are first-line for diabetic hypertension** to preserve renal function. Avoid beta-blockers and diuretics as initial therapy in this population.

**Correct Answer: C. Lisinopril**

✓ Correct Answer: B. Enalapril